Chemours Expects 2026 Sales Growth of About 2%
Chemours expects 2026 net sales to grow approximately 2% over 2025 and adjusted EBITDA to be between $775 million and $800 million.
Related stories
UMH Properties Expects 2026 Normalized FFO of $0.99-$1.03
UMH Properties expects full-year 2026 normalized FFO of $0.99-$1.03, versus a FactSet estimate of $1.
M impact | EARNINGS | Nov 02, 2026, 10:34 PM UTC
Innovative Industrial Properties Posts Q3 Adjusted FFO of $1.96
Q3 adjusted FFO was $1.96, versus the FactSet estimate of $1.71.
M impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC
5N Plus On Track to Reach High End of 2026 EBITDA Guidance
5N Plus said it is on track to achieve the high end of its full-year 2026 adjusted EBITDA guidance range.
L impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC
UMH Properties Reports Q3 Normalized FFO of $0.26
UMH Properties reported Q3 normalized FFO of $0.26, matching the FactSet estimate of $0.26.
M impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC
Toromont Reports Q3 Basic EPS of CAD 2.35
L impact | EARNINGS | Nov 02, 2026, 10:33 PM UTC
RioCan Q3 Core FFO per Unit Rises 5.1%
RioCan said third-quarter core FFO per unit rose 5.1%, citing retail occupancy strength.
M impact | EARNINGS | Nov 02, 2026, 10:32 PM UTC